• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌的L,D-转肽酶LdtMt2的结构

Structure of LdtMt2, an L,D-transpeptidase from Mycobacterium tuberculosis.

作者信息

Böth Dominic, Steiner Eva Maria, Stadler Daniela, Lindqvist Ylva, Schnell Robert, Schneider Gunter

机构信息

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-17 177 Stockholm, Sweden.

出版信息

Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):432-41. doi: 10.1107/S0907444912049268. Epub 2013 Feb 16.

DOI:10.1107/S0907444912049268
PMID:23519418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3605044/
Abstract

The transpeptidase LtdMt2 catalyzes the formation of the (3-3) cross-links characteristic of the peptidoglycan layer in the Mycobacterium tuberculosis cell wall. Bioinformatics analysis suggests that the extramembrane part of the enzyme consists of three domains: two smaller domains (denoted as A and B domains) and a transpeptidase domain (the C domain) at the C-terminus. The crystal structures of two fragments comprising the AB domains and the BC domains have been determined. The structure of the BC module, which was determined to 1.86 Å resolution using Se-SAD phasing, consists of the B domain with an immunoglobulin-related fold and the catalytic domain belonging to the ErfK/YbiS/YbnG fold family. The structure of the AB-domain fragment, which was solved by molecular replacement to 1.45 Å resolution, reveals that despite a lack of overall sequence identity the A domain is structurally very similar to the B domain. Combining the structures of the two fragments provides a view of the complete three-domain extramembrane part of LdtMt2 and shows that the protein extends at least 80-100 Å from the plasma membrane into the peptidoglycan layer and thus defines the maximal distance at which cross-links are formed by this enzyme. The LdtMt-related transpeptidases contain one or two immunoglobulin domains, which suggests that these might serve as extender units to position the catalytic domain at an appropriate distance from the membrane in the peptidoglycan layer.

摘要

转肽酶LdtMt2催化结核分枝杆菌细胞壁中肽聚糖层特有的(3-3)交联的形成。生物信息学分析表明,该酶的胞外部分由三个结构域组成:两个较小的结构域(称为A和B结构域)以及位于C端的一个转肽酶结构域(C结构域)。已经确定了包含AB结构域和BC结构域的两个片段的晶体结构。利用硒单波长反常散射法以1.86 Å的分辨率确定的BC模块结构,由具有免疫球蛋白相关折叠的B结构域和属于ErfK/YbiS/YbnG折叠家族的催化结构域组成。通过分子置换法以1.45 Å的分辨率解析的AB结构域片段的结构表明,尽管缺乏整体序列同一性,但A结构域在结构上与B结构域非常相似。将这两个片段的结构结合起来,可以看到LdtMt2完整的三结构域胞外部分的情况,并表明该蛋白从质膜延伸到肽聚糖层至少80-100 Å,从而确定了该酶形成交联的最大距离。与LdtMt相关的转肽酶含有一个或两个免疫球蛋白结构域,这表明这些结构域可能作为延伸单元,将催化结构域定位在肽聚糖层中距膜适当的距离处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/6e1af12df4d3/d-69-00432-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/c9e7ca112462/d-69-00432-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/df2162e5d740/d-69-00432-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/84b8d9eb2bee/d-69-00432-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/e35c53c083d5/d-69-00432-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/ca14babc8e49/d-69-00432-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/6e1af12df4d3/d-69-00432-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/c9e7ca112462/d-69-00432-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/df2162e5d740/d-69-00432-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/84b8d9eb2bee/d-69-00432-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/e35c53c083d5/d-69-00432-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/ca14babc8e49/d-69-00432-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118e/3605044/6e1af12df4d3/d-69-00432-fig6.jpg

相似文献

1
Structure of LdtMt2, an L,D-transpeptidase from Mycobacterium tuberculosis.结核分枝杆菌的L,D-转肽酶LdtMt2的结构
Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):432-41. doi: 10.1107/S0907444912049268. Epub 2013 Feb 16.
2
Biochemical and crystallographic studies of L,D-transpeptidase 2 from Mycobacterium tuberculosis with its natural monomer substrate.结核分枝杆菌 L,D-转肽酶 2 及其天然单体底物的生化和晶体学研究。
Commun Biol. 2024 Sep 18;7(1):1173. doi: 10.1038/s42003-024-06785-3.
3
Structures of free and inhibited forms of the L,D-transpeptidase LdtMt1 from Mycobacterium tuberculosis.结核分枝杆菌L,D-转肽酶LdtMt1的游离形式和抑制形式的结构
Acta Crystallogr D Biol Crystallogr. 2013 Sep;69(Pt 9):1697-706. doi: 10.1107/S0907444913013085. Epub 2013 Aug 15.
4
Molecular insight on the non-covalent interactions between carbapenems and L,D-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study.分子洞察碳青霉烯类抗生素与结核分枝杆菌 L,D-转肽酶 2 之间的非共价相互作用:ONIOM 研究。
J Comput Aided Mol Des. 2018 Jun;32(6):687-701. doi: 10.1007/s10822-018-0121-2. Epub 2018 May 29.
5
Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains.美罗培南抑制结核分枝杆菌L,D-转肽酶的结构基础,美罗培南是一种对广泛耐药菌株有效的药物。
Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):420-31. doi: 10.1107/S0907444912048998. Epub 2013 Feb 16.
6
Binding and processing of β-lactam antibiotics by the transpeptidase Ldt from Mycobacterium tuberculosis.结核分枝杆菌转肽酶Ldt对β-内酰胺类抗生素的结合与加工
FEBS J. 2017 Mar;284(5):725-741. doi: 10.1111/febs.14010. Epub 2017 Feb 8.
7
Loss of a Functionally and Structurally Distinct ld-Transpeptidase, LdtMt5, Compromises Cell Wall Integrity in Mycobacterium tuberculosis.功能和结构独特的赖氨酰-转肽酶LdtMt5的缺失会损害结核分枝杆菌的细胞壁完整性。
J Biol Chem. 2015 Oct 16;290(42):25670-85. doi: 10.1074/jbc.M115.660753. Epub 2015 Aug 24.
8
Crystal structure of L,D-transpeptidase LdtMt2 in complex with meropenem reveals the mechanism of carbapenem against Mycobacterium tuberculosis.与美罗培南复合的L,D-转肽酶LdtMt2的晶体结构揭示了碳青霉烯类药物抗结核分枝杆菌的机制。
Cell Res. 2013 May;23(5):728-31. doi: 10.1038/cr.2013.53. Epub 2013 Apr 16.
9
Structure and Inhibitor Specificity of L,D-Transpeptidase (LdtMt2) from Mycobacterium tuberculosis and Antibiotic Resistance: Calcium Binding Promotes Dimer Formation.结核分枝杆菌 L,D-转肽酶(LdtMt2)的结构与抑制剂特异性及抗生素耐药性:钙结合促进二聚体形成。
AAPS J. 2018 Mar 9;20(2):44. doi: 10.1208/s12248-018-0193-x.
10
Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L,D-transpeptidase 2.靶向结核分枝杆菌细胞壁:L,D-转肽酶 2 的结构与机制。
Structure. 2012 Dec 5;20(12):2103-15. doi: 10.1016/j.str.2012.09.016. Epub 2012 Oct 25.

引用本文的文献

1
Biochemical and crystallographic studies of L,D-transpeptidase 2 from Mycobacterium tuberculosis with its natural monomer substrate.结核分枝杆菌 L,D-转肽酶 2 及其天然单体底物的生化和晶体学研究。
Commun Biol. 2024 Sep 18;7(1):1173. doi: 10.1038/s42003-024-06785-3.
2
Drug Discovery in the Field of β-Lactams: An Academic Perspective.β-内酰胺类药物研发:学术视角
Antibiotics (Basel). 2024 Jan 8;13(1):59. doi: 10.3390/antibiotics13010059.
3
The structural basis for deubiquitination by the fingerless USP-type effector TssM.

本文引用的文献

1
Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L,D-transpeptidase 2.靶向结核分枝杆菌细胞壁:L,D-转肽酶 2 的结构与机制。
Structure. 2012 Dec 5;20(12):2103-15. doi: 10.1016/j.str.2012.09.016. Epub 2012 Oct 25.
2
Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis.美罗培南抑制结核分枝杆菌 D,D-羧肽酶活性。
Mol Microbiol. 2012 Oct;86(2):367-81. doi: 10.1111/j.1365-2958.2012.08199.x. Epub 2012 Aug 28.
3
Structural perspective of peptidoglycan biosynthesis and assembly.
无指型 USP 效应因子 TssM 的去泛素化作用的结构基础。
Life Sci Alliance. 2023 Dec 13;7(2). doi: 10.26508/lsa.202302422. Print 2024 Feb.
4
High-throughput screen with the l,d-transpeptidase Ldt of reveals novel classes of covalently reacting inhibitors.对L,d-转肽酶Ldt进行高通量筛选,发现了新型共价反应抑制剂。
Chem Sci. 2023 May 30;14(26):7262-7278. doi: 10.1039/d2sc06858c. eCollection 2023 Jul 5.
5
T405, a New Penem, Exhibits Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren.T405,一种新型 Penem,对 M. abscessus 具有疗效,并与β-内酰胺类药物亚胺培南和头孢地尼具有协同作用。
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0053622. doi: 10.1128/aac.00536-22. Epub 2022 May 31.
6
Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen.结核分枝杆菌细胞壁肽聚糖:结核致病病原体的阿喀琉斯之踵。
FEMS Microbiol Rev. 2019 Sep 1;43(5):548-575. doi: 10.1093/femsre/fuz016.
7
Isolation, Purification and Characterization of L,D-transpeptidase 2 from Mycobacterium tuberculosis.
Acta Naturae. 2019 Jan-Mar;11(1):23-28.
8
Dual-Specificity Phosphatase CDC25B Was Inhibited by Natural Product HB-21 Through Covalently Binding to the Active Site.双特异性磷酸酶CDC25B被天然产物HB-21通过共价结合活性位点所抑制。
Front Chem. 2018 Nov 13;6:531. doi: 10.3389/fchem.2018.00531. eCollection 2018.
9
Molecular insight on the non-covalent interactions between carbapenems and L,D-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study.分子洞察碳青霉烯类抗生素与结核分枝杆菌 L,D-转肽酶 2 之间的非共价相互作用:ONIOM 研究。
J Comput Aided Mol Des. 2018 Jun;32(6):687-701. doi: 10.1007/s10822-018-0121-2. Epub 2018 May 29.
10
Structure and Inhibitor Specificity of L,D-Transpeptidase (LdtMt2) from Mycobacterium tuberculosis and Antibiotic Resistance: Calcium Binding Promotes Dimer Formation.结核分枝杆菌 L,D-转肽酶(LdtMt2)的结构与抑制剂特异性及抗生素耐药性:钙结合促进二聚体形成。
AAPS J. 2018 Mar 9;20(2):44. doi: 10.1208/s12248-018-0193-x.
肽聚糖生物合成和组装的结构视角。
Annu Rev Biochem. 2012;81:451-78. doi: 10.1146/annurev-biochem-061809-112742.
4
Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins.碳青霉烯类和头孢菌素类药物对结核分枝杆菌 l,d-转肽酶 LdtMt₁的灭活作用。
Antimicrob Agents Chemother. 2012 Aug;56(8):4189-95. doi: 10.1128/AAC.00665-12. Epub 2012 May 21.
5
Dynamics induced by β-lactam antibiotics in the active site of Bacillus subtilis L,D-transpeptidase.β-内酰胺抗生素在枯草芽孢杆菌 L,D-转肽酶活性部位的动力学诱导作用。
Structure. 2012 May 9;20(5):850-61. doi: 10.1016/j.str.2012.03.015.
6
Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo.美罗培南-克拉维酸在体内显示出对结核分枝杆菌的活性。
Antimicrob Agents Chemother. 2012 Jun;56(6):3384-7. doi: 10.1128/AAC.05690-11. Epub 2012 Mar 26.
7
Mycobacterium tuberculosis: success through dormancy.结核分枝杆菌:休眠中的成功之道。
FEMS Microbiol Rev. 2012 May;36(3):514-32. doi: 10.1111/j.1574-6976.2012.00331.x. Epub 2012 Mar 8.
8
New tuberculosis drugs on the horizon.新型结核病药物问世在望。
Curr Opin Microbiol. 2011 Oct;14(5):570-6. doi: 10.1016/j.mib.2011.07.022. Epub 2011 Aug 5.
9
Distinct pathways for modification of the bacterial cell wall by non-canonical D-amino acids.非典型 D-氨基酸对细菌细胞壁的修饰途径不同。
EMBO J. 2011 Jul 26;30(16):3442-53. doi: 10.1038/emboj.2011.246.
10
REFMAC5 for the refinement of macromolecular crystal structures.用于大分子晶体结构精修的REFMAC5
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. doi: 10.1107/S0907444911001314. Epub 2011 Mar 18.